- Recent Funding
- Investors
- Boehringer Ingelheim
Boehringer Ingelheim portfolio
Boehringer Ingelheim has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Click Therapeutics's $50M Series B+ round in April 2026, which it led. That company is in Health and bio.
What Boehringer Ingelheim invests in
- Health and bio · 1 · 100%
How Boehringer Ingelheim invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $50M |
Boehringer Ingelheim portfolio companies
CClick Therapeutics$50MSeries B+ · Apr 2026
| Company | Round with Boehringer Ingelheim | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $50M · lead | $50M | Apr 13, 2026 Series B+ |
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Boehringer Ingelheim. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Boehringer Ingelheim, which is a subset of its real portfolio. API: /api/v1/investors/boehringer-ingelheim (get a free API key). More: the most active VC firms and new venture capital funds.